| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.89▼ | 0.89▼ | 0.89▼ | 0.93▼ | 1.06▼ |
| MA10 | 0.92▼ | 0.92▼ | 0.93▼ | 1.01▼ | 1.14▼ |
| MA20 | 0.95▼ | 0.95▼ | 0.96▼ | 1.08▼ | 1.30▼ |
| MA50 | 0.97▼ | 1.00▼ | 1.04▼ | 1.17▼ | 1.37▼ |
| MA100 | 1.00▼ | 1.08▼ | 1.10▼ | 1.34▼ | 1.48▼ |
| MA200 | 1.06▼ | 1.13▼ | 1.16▼ | 1.40▼ | 1.48▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.006▼ | -0.006▼ | -0.021▼ | -0.045▼ |
| RSI | 33.561▼ | 31.843▼ | 31.426▼ | 27.921▼ | 31.157▼ |
| STOCH | 21.346 | 21.346 | 14.929▼ | 6.372▼ | 10.061▼ |
| WILL %R | -99.092▼ | -99.172▼ | -99.251▼ | -98.800▼ | -99.693▼ |
| CCI | -126.739▼ | -123.289▼ | -128.964▼ | -129.665▼ | -147.871▼ |
|
Monday, February 02, 2026 04:32 AM
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that our ...
|
|
Wednesday, January 28, 2026 11:44 PM
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
|
|
Tuesday, January 20, 2026 04:02 AM
SHELTON, CT / ACCESS Newswire / January 20, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/02/26 | 0.93 | 0.93 | 0.8642 | 0.8642 | 173,541 |
| 04/02/26 | 0.96 | 0.96 | 0.86 | 0.90 | 531,500 |
| 03/02/26 | 0.98 | 0.9949 | 0.9506 | 0.9635 | 173,702 |
| 02/02/26 | 0.97 | 1.01 | 0.95 | 0.98 | 156,404 |
| 30/01/26 | 1.00 | 1.0099 | 0.9601 | 0.965 | 197,530 |
| 29/01/26 | 1.03 | 1.04 | 0.99 | 1.00 | 371,912 |
| 28/01/26 | 1.0799 | 1.0799 | 1.04 | 1.05 | 355,705 |
| 27/01/26 | 1.12 | 1.13 | 1.05 | 1.08 | 352,468 |
| 26/01/26 | 1.14 | 1.1635 | 1.11 | 1.11 | 358,409 |
| 23/01/26 | 1.15 | 1.16 | 1.13 | 1.15 | 259,545 |
|
|
||||
|
|
||||
|
|